NCT07769502
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07769502
Title A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR

Facility Status City State Zip Country Details
Hattiesburg Clinic /ID# 281952 RECRUITING Hattiesburg Mississippi 39401 United States Details
The Chaim Sheba Medical Center /ID# 281618 RECRUITING Ramat Gan Tel Aviv 5265601 Israel Details
Hadassah Medical Center-Hebrew University /ID# 281620 RECRUITING Jerusalem 91120 Israel Details
Kanagawa Cancer Center /ID# 281899 RECRUITING Yokohama Kanagawa 241-8515 Japan Details
Osaka International Cancer Institute /ID# 281900 RECRUITING Osaka Osaka 5418567 Japan Details
National Cancer Center Hospital /ID# 281870 RECRUITING Chuo-Ku Tokyo 104-0045 Japan Details
China Medical University Hospital /ID# 281981 RECRUITING Taichung 40447 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field